Rule 4.7B Appendix 4C Quarterly cash flow report for entities subject to Listing Rule 4.7B Name of entity NEXALIS THERAPEUTICS LTD ABN Quarter ended (“current quarter”) 90 611 845 820 30 September 2026 Consolidated statement of cash flows Current quarter Year to date (9 $A’000 months)...